HOME >> BIOLOGY >> NEWS
Leading cause of US food-borne illness makes its own pathway through cells

New Haven, Conn. -- Yale researchers now have some answers about how the bacterium that is the leading cause of food-borne illness in the United States enters cells of the gut and avoids detection and destruction, according to a presentation at the annual meeting of the American Society for Cell Biology in San Diego in December.

While scientists are just beginning to answer basic questions about how Campylobacter jejuni (campylobacter) causes infection, Robert Watson, a graduate student in the Section of Microbial Pathogenesis at Yale University School of Medicine worked out a better way to study the bacteria and reported that it takes an uncommon path as it infects cells.

Since the intestinal lining cells that campylobacter infects do not normally take up bacteria -- or any particles as large as bacteria -- Watson and his advisor, Jorge Galn, the Lucille P Markey Professor of Microbiology and Cell Biology, set out to investigate the path of infection through cells. They found that campylobacter apparently enters into the endocytic pathway that cells use to recycle molecules from their surface. It then quickly diverts its path, creating its own intracellular network of campylobacter-filled vacuoles, or cellular pockets, that make their way toward the nucleus, and finally locate near the cell's transportation hub, the Golgi apparatus.

"It's been known for over two decades that campylobacter can enter intestinal epithelial cells -- but until now no one could show how it was taken up or where it localized. That suggested it had evolved a special mechanism for uptake," said Watson. "Campylobacter seems to have found a special access to these cells and established its own intracellular niche."

The U.S. Centers for Disease Control and Prevention estimates that "campylobacteriosis," one of the most common causes of diarrhea worldwide, strikes 2.4 million Americans a year. Most sufferers recover after a few unpleasant days, but it can
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
11-Jan-2007


Page: 1 2 3

Related biology news :

1. Leading the fight against food poisoning
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
4. Leading scientists elected to EMBO ranks
5. Leading scientists gather to discuss developments in infectious disease research
6. Leading stem cell expert moves to UK
7. Leading breast cancer researcher awarded new lectureship
8. Leading experts confront global burden of chronic disease 8 Dec. at Abelson Science Seminar
9. Leading researchers from Israel and Southern California to present stem cell symposium
10. Leading experts present latest in cancer prevention research
11. Leading lampreys to slaughter: Pheromone for scourge of Great Lakes identified

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
(Date:6/23/2020)... KEYNES, England (PRWEB) , ... June 23, 2020 ... ... in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer ... response project to support testing operations in the fight against the COVID-19 pandemic ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/1/2020)... CHARLOTTE, N.C. (PRWEB) , ... June 29, 2020 ... ... has reported year to date growth of 40% in 2020, despite many obstacles ... medical technology, MedShift aims to increase revenue for its partnered medical practices and ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., ... presented June 22-24 during the American Association for Cancer Research Virtual meeting. One ... the potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
Breaking Biology Technology:
Cached News: